180 related articles for article (PubMed ID: 35948343)
1. Therapeutic effects of antidepressants for global improvement and subdomain symptoms of autism spectrum disorder: a systematic review and meta-analysis.
Liang SC; Sun CK; Fan HY; Chung W; Tzang RF; Hung KC; Chiu HJ; Cheng YS; Yeh PY
J Psychiatry Neurosci; 2022; 47(4):E299-E310. PubMed ID: 35948343
[TBL] [Abstract][Full Text] [Related]
2. Tricyclic antidepressants for autism spectrum disorders (ASD) in children and adolescents.
Hurwitz R; Blackmore R; Hazell P; Williams K; Woolfenden S
Cochrane Database Syst Rev; 2012 Mar; (3):CD008372. PubMed ID: 22419332
[TBL] [Abstract][Full Text] [Related]
3. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
[TBL] [Abstract][Full Text] [Related]
4. Antidepressants for people with epilepsy and depression.
Maguire MJ; Weston J; Singh J; Marson AG
Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010682. PubMed ID: 25464360
[TBL] [Abstract][Full Text] [Related]
5. Antidepressants for people with epilepsy and depression.
Maguire MJ; Marson AG; Nevitt SJ
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531
[TBL] [Abstract][Full Text] [Related]
6. The pediatric psychopharmacology of autism spectrum disorder: A systematic review - Part I: The past and the present.
Persico AM; Ricciardello A; Lamberti M; Turriziani L; Cucinotta F; Brogna C; Vitiello B; Arango C
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Aug; 110():110326. PubMed ID: 33857522
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease.
Pollok J; van Agteren JE; Carson-Chahhoud KV
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012346. PubMed ID: 30566235
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis.
Siafis S; Çıray O; Wu H; Schneider-Thoma J; Bighelli I; Krause M; Rodolico A; Ceraso A; Deste G; Huhn M; Fraguas D; San José Cáceres A; Mavridis D; Charman T; Murphy DG; Parellada M; Arango C; Leucht S
Mol Autism; 2022 Mar; 13(1):10. PubMed ID: 35246237
[TBL] [Abstract][Full Text] [Related]
9. Pharmacotherapy of restricted/repetitive behavior in autism spectrum disorder:a systematic review and meta-analysis.
Yu Y; Chaulagain A; Pedersen SA; Lydersen S; Leventhal BL; Szatmari P; Aleksic B; Ozaki N; Skokauskas N
BMC Psychiatry; 2020 Mar; 20(1):121. PubMed ID: 32164636
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of serotonergic antidepressant treatment for the neuropsychiatric symptoms and agitation in dementia: A systematic review and meta-analysis.
Hsu TW; Stubbs B; Liang CS; Chen TY; Yeh TC; Pan CC; Chu CS
Ageing Res Rev; 2021 Aug; 69():101362. PubMed ID: 34000464
[TBL] [Abstract][Full Text] [Related]
11. Newer generation antidepressants for depressive disorders in children and adolescents.
Hetrick SE; McKenzie JE; Cox GR; Simmons MB; Merry SN
Cochrane Database Syst Rev; 2012 Nov; 11(11):CD004851. PubMed ID: 23152227
[TBL] [Abstract][Full Text] [Related]
12. Maternal SSRI exposure increases the risk of autistic offspring: A meta-analysis and systematic review.
Andalib S; Emamhadi MR; Yousefzadeh-Chabok S; Shakouri SK; Høilund-Carlsen PF; Vafaee MS; Michel TM
Eur Psychiatry; 2017 Sep; 45():161-166. PubMed ID: 28917161
[TBL] [Abstract][Full Text] [Related]
13. Antidepressants versus placebo for panic disorder in adults.
Bighelli I; Castellazzi M; Cipriani A; Girlanda F; Guaiana G; Koesters M; Turrini G; Furukawa TA; Barbui C
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD010676. PubMed ID: 29620793
[TBL] [Abstract][Full Text] [Related]
14. Use of selective serotonin and norepinephrine reuptake inhibitors (SNRIs) in the treatment of autism spectrum disorder (ASD), comorbid psychiatric disorders and ASD-associated symptoms: a clinical review.
Nanjappa MS; Voyiaziakis E; Pradhan B; Mannekote Thippaiah S
CNS Spectr; 2022 Jun; 27(3):290-297. PubMed ID: 33280640
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of Antidepressants for the Treatment of Irritable Bowel Syndrome: A Meta-Analysis.
Xie C; Tang Y; Wang Y; Yu T; Wang Y; Jiang L; Lin L
PLoS One; 2015; 10(8):e0127815. PubMed ID: 26252008
[TBL] [Abstract][Full Text] [Related]
16. Antidepressants for the treatment of depression in people with cancer.
Ostuzzi G; Matcham F; Dauchy S; Barbui C; Hotopf M
Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011006. PubMed ID: 26029972
[TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapy for anxiety and comorbid alcohol use disorders.
Ipser JC; Wilson D; Akindipe TO; Sager C; Stein DJ
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD007505. PubMed ID: 25601826
[TBL] [Abstract][Full Text] [Related]
18. Subjective and objective sleep alterations in medication-naïve children and adolescents with autism spectrum disorder: a systematic review and meta-analysis.
Kim H; Kim JH; Kim J; Kim JY; Cortese S; Smith L; Koyanagi A; Radua J; Fusar-Poli P; Carvalho AF; Salazar de Pablo G; Shin JI; Cheon KA; Solmi M
Epidemiol Psychiatr Sci; 2023 Jul; 32():e48. PubMed ID: 37469173
[TBL] [Abstract][Full Text] [Related]
19. Practitioner Review: Pharmacological treatment of attention-deficit/hyperactivity disorder symptoms in children and youth with autism spectrum disorder: a systematic review and meta-analysis.
Rodrigues R; Lai MC; Beswick A; Gorman DA; Anagnostou E; Szatmari P; Anderson KK; Ameis SH
J Child Psychol Psychiatry; 2021 Jun; 62(6):680-700. PubMed ID: 32845025
[TBL] [Abstract][Full Text] [Related]
20. Agomelatine versus other antidepressive agents for major depression.
Guaiana G; Gupta S; Chiodo D; Davies SJ; Haederle K; Koesters M
Cochrane Database Syst Rev; 2013 Dec; (12):CD008851. PubMed ID: 24343836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
